Iona Millwood
DPhil
Senior Epidemiologist; University Research Lecturer
Iona Millwood completed an undergraduate degree in Natural Sciences at the University of Cambridge and a DPhil in Molecular Genetics at the University of Oxford. She worked as a postdoctoral research associate at Imperial College London, on large-scale genetic epidemiological projects including the Northern Finland Birth Cohorts, and also spent several years as a Lecturer at the University of New South Wales, Australia, developing and conducting clinical trials for biomedical methods of HIV prevention in Australia and South-East Asia.
Iona joined the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) in 2009, to work on the China Kadoorie Biobank (CKB), including designing and conducting genomic and multi-omic assays to enhance and develop the CKB resources. Current research interests focus on using genetic and molecular epidemiology to understand the aetiology of cardio-metabolic and other chronic diseases, using genetic approaches to identify and evaluate potential drug targets, and investigating the role of infection in cancer risk, and the health effects of alcohol consumption. Iona co-leads a Genetic Epidemiology module for the MSc in Global Health Science and Epidemiology.
Recent publications
-
Investigation into the Health Effects of Reduced Chymase Function Using Predicted Loss-of-Function Mutations in CMA1.
Journal article
Fairhurst-Hunter Z. et al, (2022), J Cardiovasc Transl Res
-
Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer
Journal article
MILLWOOD I. and WALTERS R., (2022), Cancer Causes and Control
-
Polygenic risk scores for prediction of breast cancer risk in Asian populations.
Journal article
Ho W-K. et al, (2021), Genet Med
-
The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study.
Journal article
Yang L. et al, (2021), Lancet Public Health, 6, e888 - e896
-
Alcohol drinking and risks of liver cancer and non-neoplastic chronic liver diseases in China: a 10-year prospective study of 0.5 million adults.
Journal article
Im PK. et al, (2021), BMC Med, 19